Bio-Rad Laboratories, Inc.
US ˙ NYSE ˙ US0905722072

SecurityBIO / Bio-Rad Laboratories, Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Squarepoint Ops LLC closes position in BIO / Bio-Rad Laboratories, Inc.

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 0 shares of Bio-Rad Laboratories, Inc. (US:BIO) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 5,425 shares of Bio-Rad Laboratories, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIO RAD LABS CL A 090572207 0 -100.00 0
2026-02-13 2025-12-31 13F BIO RAD LABS CL A 090572207 5,425 -49,310 -90.09 1,644 -89.29 0.0017
2025-11-14 2025-09-30 13F BIO RAD LABS CL A 090572207 54,735 54,735 15,347 0.0154
2025-08-27 2025-03-31 13F/A-1 BIO RAD LABS CL A 090572207 0 -13,174 -100.00 0 -100.00
2025-05-15 2025-03-31 13F BIO RAD LABS CL A 090572207 0 0
2025-02-14 2024-12-31 13F BIO RAD LABS CL A 090572207 13,174 -8,712 -39.81 4,328 -40.90 0.0043
2024-11-14 2024-09-30 13F BIO RAD LABS CL A 090572207 21,886 -4,025 -15.53 7,323 3.48 0.0115
2024-08-14 2024-06-30 13F BIO RAD LABS CL A 090572207 25,911 -34,691 -57.24 7,077 -66.24 0.0117
2024-05-15 2024-03-31 13F BIO RAD LABS CL A 090572207 60,602 -78,525 -56.44 20,960 -53.34 0.0361
2024-02-14 2023-12-31 13F BIO RAD LABS CL A 090572207 139,127 98,098 239.09 44,923 205.47 0.0850
2023-11-14 2023-09-30 13F BIO RAD LABS CL A 090572207 41,029 11,122 37.19 14,707 29.71 0.0363
2023-08-14 2023-06-30 13F BIO RAD LABS CL A 090572207 29,907 29,907 11,338 0.0347
2022-08-15 2022-06-30 13F BIO RAD LABS CL A 090572207 0 -24,482 -100.00 0 -100.00
2022-05-16 2022-03-31 13F BIO RAD LABS CL A 090572207 24,482 12,413 102.85 13,789 51.21 0.0590
2022-02-14 2021-12-31 13F BIO RAD LABS CL A 090572207 12,069 9,807 433.55 9,119 440.55 0.0241
2021-11-15 2021-09-30 13F BIO RAD LABS CL A 090572207 2,262 -5,255 -69.91 1,687 -65.17 0.0048
2021-08-16 2021-06-30 13F BIO RAD LABS CL A 090572207 7,517 -10,598 -58.50 4,843 -53.19 0.0184
2021-05-17 2021-03-31 13F BIO RAD LABS CL A 090572207 18,115 17,430 2,544.53 10,347 2,493.23 0.0606
2021-02-16 2020-12-31 13F BIO RAD LABS CL A 090572207 685 -899 -56.76 399 -51.10 0.0030
2020-11-16 2020-09-30 13F BIO RAD LABS CL A 090572207 1,584 -17,884 -91.86 816 -90.72 0.0110
2020-08-14 2020-06-30 13F BIO RAD LABS CL A 090572207 19,468 6,030 44.87 8,790 86.58 0.1422
2020-05-15 2020-03-31 13F BIO RAD LABS CL A 090572207 13,438 819 6.49 4,711 0.90 0.1205
2020-02-14 2019-12-31 13F BIO RAD LABS CL A 090572207 12,619 -44,667 -77.97 4,669 -75.50 0.0278
2019-11-14 2019-09-30 13F BIO RAD LABS CL A 090572207 57,286 57,286 19,061 0.1702
2019-08-14 2019-06-30 13F BIO RAD LABS CL A 090572207 0 -36,892 -100.00 0 -100.00
2019-05-15 2019-03-31 13F BIO RAD LABS CL A 090572207 36,892 36,892 11,277 0.1194
2019-02-14 2018-12-31 13F BIO RAD LABS CL A 090572207 0 -3,166 -100.00 0 -100.00
2018-11-14 2018-09-30 13F BIO RAD LABS CL A 090572207 3,166 -8,337 -72.48 991 -70.14 0.0119
2018-08-14 2018-06-30 13F BIO RAD LABS CL A 090572207 11,503 3,088 36.70 3,319 57.75 0.0440
2018-05-15 2018-03-31 13F BIO RAD LABS CL A 090572207 8,415 4,614 121.39 2,104 131.97 0.0334
2018-02-14 2017-12-31 13F BIO RAD LABS CL A 090572207 3,801 915 31.70 907 41.50 0.0158
2017-11-14 2017-09-30 13F BIO RAD LABS CL A 090572207 2,886 911 46.13 641 43.40 0.0123
2017-08-14 2017-06-30 13F BIO RAD LABS CL A 090572207 1,975 1,975 447 0.0088
2016-08-15 2016-06-30 13F BIO RAD LABS CL A 090572207 0 -5,169 -100.00 0 -100.00
2016-05-16 2016-03-31 13F BIO RAD LABS CL A 090572207 5,169 2,940 131.90 707 128.80 0.0548
2016-02-16 2015-12-31 13F BIO RAD LABS CL A 090572207 2,229 2,229 0.00 309 0.0339
2015-08-14 2015-06-30 13F BIO RAD LABS CL A 090572207 0 -4,372 -100.00 0 -100.00
2015-05-19 2015-03-31 13F/A-1 BIO RAD LABS CL A 090572207 4,372 4,372 591 0.2070
2015-05-15 2015-03-31 13F BIO RAD LABS CL A 090572207 4,372 591 0.2070
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.